However, it is uncertain whether the differences in WBCs and myeloblasts are affected by differences in germline and somatic TET2 mutations because previous articles reported that AML patients with TET2 mutations have a higher WBC count [34, 40]. Here, TET2 is linked to acute myeloid leukemia.